Overview Regulatory Nebilet PMS Status: Completed Trial end date: 2011-01-01 Target enrollment: Participant gender: Summary An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and effectiveness of Nebivolol administered in Korean patients according to the prescribing information Details Lead Sponsor: GlaxoSmithKlineTreatments: Nebivolol